Preferential induction of electrically mediated cell death from applied pulses
First Claim
1. A method for inducing necrosis in susceptible malignant cells, comprising the steps:
- a) positioning a collection of cells containing the susceptible malignant cells within a treatment domain;
b) subjecting said treatment domain to a non-ionizing radiation field;
c) pulsing said non-ionizing radiation field with a frequency and an intensity selected to produce necrosis in the susceptible malignant cells; and
d) creating by said pulsing a transmembrane potential that causes an increase in ionic diffusion in the susceptible malignant cells or generates reversible electroporation of the susceptible malignant cells.
1 Assignment
0 Petitions
Accused Products
Abstract
A method for inducing necrosis in susceptible malignant cells, comprises two general steps. First, positioning a collection of cells containing the susceptible malignant cells within a treatment domain, wherein the treatment domain is subjected to a non-ionizing radiation field. Second, pulsing said non-ionizing radiation field with a frequency and an intensity selected to produce necrosis in the susceptible malignant cells by creating a transmembrane potential that causes an increase in ionic diffusion in the susceptible malignant cells or generates reversible electroporation of the susceptible malignant cells. Though both malignant and non-malignant cells may be reversibly porated, it is posited that many forms of cancer will be more vulnerable to the subject procedure.
262 Citations
26 Claims
-
1. A method for inducing necrosis in susceptible malignant cells, comprising the steps:
-
a) positioning a collection of cells containing the susceptible malignant cells within a treatment domain; b) subjecting said treatment domain to a non-ionizing radiation field; c) pulsing said non-ionizing radiation field with a frequency and an intensity selected to produce necrosis in the susceptible malignant cells; and d) creating by said pulsing a transmembrane potential that causes an increase in ionic diffusion in the susceptible malignant cells or generates reversible electroporation of the susceptible malignant cells. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A method for inducing necrosis in susceptible malignant cells, comprising the steps:
-
a) positioning a collection of cells containing the susceptible malignant cells within a treatment domain; b) subjecting said treatment domain to a non-ionizing radiation field; c) pulsing said non-ionizing radiation field with pulses having a pulse duration, interval gap between pulses, and pulse intensity selected to produce necrosis in the susceptible malignant cells; and d) creating by said pulsing a transmembrane potential that causes an increase in ionic diffusion in the susceptible malignant cells or generates reversible electroporation of the susceptible malignant cells, thereby causing a lethal metabolic alteration in the susceptible malignant cells. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. A method for treating a patient having malignant cells, wherein the treatment induces necrosis in the malignant cells that are susceptible to said treatment, comprising the steps:
-
a) selecting the patient with the malignant cells that are susceptible to the treatment because the susceptible malignant cells produce ATP primarily through glycolytic pathways or the susceptible malignant cells have a variant ion gradient relative to nonsusceptible healthy cells; b) positioning the patient to place the susceptible malignant cells within a treatment domain; c) subjecting said treatment domain to a non-ionizing radiation field; and d) pulsing said non-ionizing radiation field with pulses having a pulse duration, interval gap between pulses, and pulse intensity selected to produce necrosis in the susceptible malignant cells by creating a transmembrane potential that causes an increase in ionic diffusion in the susceptible malignant cells or generates reversible electroporation of the susceptible malignant cells, thereby causing a lethal metabolic alteration in the susceptible malignant cells. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26)
-
Specification